ES8505406A1 - Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos - Google Patents

Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos

Info

Publication number
ES8505406A1
ES8505406A1 ES531436A ES531436A ES8505406A1 ES 8505406 A1 ES8505406 A1 ES 8505406A1 ES 531436 A ES531436 A ES 531436A ES 531436 A ES531436 A ES 531436A ES 8505406 A1 ES8505406 A1 ES 8505406A1
Authority
ES
Spain
Prior art keywords
obtaining
procedure
hcmvs
hybridomes
isolating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531436A
Other languages
English (en)
Other versions
ES531436A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Santé et de la Recherche Médicale
Institut Pasteur
Original Assignee
Institut National de la Santé et de la Recherche Médicale
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Santé et de la Recherche Médicale, Institut Pasteur filed Critical Institut National de la Santé et de la Recherche Médicale
Publication of ES8505406A1 publication Critical patent/ES8505406A1/es
Publication of ES531436A0 publication Critical patent/ES531436A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO DE PRODUCIR HIBRIDOMAS SECRETORES DE ANTICUERPOS.COMPRENDE: A) HACER REACCIONAR A LOS ANTICUERPOS NEUTRALIZANTES CON UNAS CELULAS HUMANAS EN CULTIVOS PREVIAMENTE INFECTADOS CON UN HCMV, FIJADAS CON ACETONA, Y SECADAS AL AIRE; B) EFECTUAR UNA PRIMERA SELECCION DE LOS CLONES QUE DEN LUGAR A UNA REACCION DE FIJACION, DETECTABLE POR INMUNOFLUORESCENCIA SOBRE LAS CELULAS HUMANAS Y UNA SEGUNDA SELECCION DE LOS ANTICUERPOS MONOCLONALES RETENIDAS AL FINAL DE LA PRIMERA SELECCION, QUE REACCIONAN SELECTIVAMENTE CON UNA PROTEINA VIRAL, INDUCIDA EN EL CITOPLASMA DE LAS CELULAS INFECTADAS, OBTENIDA A PARTIR DE ESTE, Y CONTENIDA EN UNA FRACCION POLIPEPTIDICA PRODUCIDA A PARTIR DEL CITOPLASMA, DESPUES DE SEPARACION PREVIA DE LAS PROTEINAS O POLIPEPTIDOS QUE TIENEN PESOS MOLECULARES DIFERENTES, Y C) RECUPERAR EL ANTICUERPO SELECCIONADO A PARTIR DE LOS PRODUCTOS DE REACCION OBTENIDOS.
ES531436A 1983-03-31 1984-03-30 Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos Granted ES531436A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8305384A FR2543570B1 (fr) 1983-03-31 1983-03-31 Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains

Publications (2)

Publication Number Publication Date
ES8505406A1 true ES8505406A1 (es) 1985-06-01
ES531436A0 ES531436A0 (es) 1985-06-01

Family

ID=9287460

Family Applications (2)

Application Number Title Priority Date Filing Date
ES531436A Granted ES531436A0 (es) 1983-03-31 1984-03-30 Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
ES540009A Granted ES540009A0 (es) 1983-03-31 1985-01-31 Procedimiento de obtencion de polipeptidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES540009A Granted ES540009A0 (es) 1983-03-31 1985-01-31 Procedimiento de obtencion de polipeptidos

Country Status (4)

Country Link
EP (1) EP0122841A1 (es)
JP (1) JPS59231026A (es)
ES (2) ES531436A0 (es)
FR (1) FR2543570B1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404368D0 (en) * 1984-02-20 1984-03-28 Cogent Ltd Monoclonal antibodies to human cytomegalovirus
US4783399A (en) * 1984-05-04 1988-11-08 Scripps Clinic And Research Foundation Diagnostic system for the detection of cytomegalovirus
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
WO1987003602A1 (fr) * 1985-12-06 1987-06-18 Teijin Limited Anticorps monoclonal humain contre le virus megalocytique et procede de preparation dudit anticorps
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
EP0376973A1 (en) * 1987-08-07 1990-07-11 The Children's Hospital, Incorporated Monoclonal antibodies reactive with cytomegalovirus glycoprotein a
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
PE20141398A1 (es) 2008-07-16 2014-10-18 Inst Research In Biomedicine Anticuerpos neutralizantes de citomegalovirus humano
AU2010334809C1 (en) 2009-12-23 2015-02-26 Agenus Inc. Binding members for human cytomegalovirus

Also Published As

Publication number Publication date
FR2543570B1 (fr) 1985-08-09
EP0122841A1 (fr) 1984-10-24
FR2543570A1 (fr) 1984-10-05
ES8601307A1 (es) 1985-11-16
ES531436A0 (es) 1985-06-01
ES540009A0 (es) 1985-11-16
JPS59231026A (ja) 1984-12-25

Similar Documents

Publication Publication Date Title
AU573523B2 (en) Functional human urokinase proteins
NO2012001I1 (no) Ipilimumab (INN) - krav i basispatent
FI893702A7 (fi) Menetelmä ihmisen seerumialbumiinin ja muiden heterologisten proteiinien mikrobiologiseksi valmistamiseksi hiivasta
GR3018773T3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods.
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
ES2056817T3 (es) Transformacion de trichoderma.
ES2124215T3 (es) Unos anticuerpos monoclonales al fiv y polipeptidos relacionados y su metodo de obtencion.
AU525403B2 (en) Purified antigen
IE832452L (en) Lymphocyte growth factor
ES474697A1 (es) Un procedimiento para preparar interferon de leucocito por- cino exogeno
ES531436A0 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
ES8106834A1 (es) Un metodo de producir un antisuero que tiene una mejor cua- lidad aglutinante
DK447784A (da) Immuninterferon
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants
SU1545614A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o